Expression of nerve growth factor and epidermal growth factor receptors in neural nevi with nevic corpuscles

American Journal of Dermatopathology

Volumn 18, Issue 5, 1996, Pages 460-464

  Argenyi, Zsolt B ^a   Rodgers, Janis ^a   Wick, Mark ^b  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Epidermal growth factor receptor; Immunohistochemistry; Melanocytic nevi; Nerve growth factor receptor; Neural nevi; Nevic corpuscles

Indexed keywords

AVIDIN; BIOTIN; EPIDERMAL GROWTH FACTOR RECEPTOR; NERVE GROWTH FACTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JUVENILE MELANOMA; MAJOR CLINICAL STUDY; MALE; MELANOCYTIC NEVUS; MELANOMA; NERVE CELL DIFFERENTIATION; NEVUS; PRIORITY JOURNAL;

ADULT; AGED; CELL DIFFERENTIATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEVUS, PIGMENTED; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, NERVE GROWTH FACTOR; SCHWANN CELLS; SKIN NEOPLASMS;

EID: 0029954981     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000372-199610000-00003     Document Type: Article

References (36)

1. Cramer SF. The origin of epidermal melanocytes: implications for the histogenesis of nevi and melanomas. Arch Pathol Lab Med 1991;115:115-9.
2. Funan Hu. Aging of melanocytes. J Invest Dermatol 1979;73:70-9.
3. Goovaerts G, Buyssens N. Nevus cell maturation or atrophy? Am J Dermatopathol 1988;10:20-7.
4. Curran RC, McCann BG. The ultrastructure of benign pigmented naevi and melanocarcinomas in man. J Pathol 1976;119:135-46.
5. Gottlieb B, Brown AL, Winkelmann RK. Fine structure of the nevus cell. Arch Dermatol 1965;92:81-7.
6. Maize JC, Foster G. Age-related changes in melanocytic naevi. Clin Exp Dermatol 1979;4:49-58.
7. Stegmaier OC. Natural regression of the melanocytic nevus. J Invest Dermatol 1952;32:413-9.
8. Jurecka W, Lassmann H, Gebhart W. The relation of nervous elements to intradermal nevi: an electron microscopic study. Arch Dermatol 1978;261:219-30.
9. Szekeres L. Nerves and nerve endings in pigmented nevi: part I. Arch Dermatol Res 1975;252:11-6.
10. Aso M, Hashimoto K, Eto H, et al. Expression of Schwann cell characteristics in pigmented nevus: immunohistochemical study using monoclonal antibody to Schwann cell associated antigen. Cancer 1988;62:938-43.
11. Masson P. Les naevi pigmentaires, tumeurs nerveuses. Ann Ant Patol Med Chir (Paris) 1926:3:417-53, 657-96.
12. Niizuma K. Electron microscopic study of nevic corpuscle. Acta Derm Venereol (Stockh) 1975;55:283-9.
13. Sueki H, Iwai M, Kato H, et al. Immunohistochemical and electron microscopic observations of nevic corpuscle. J Cutan Pathol 1984;11:140-8.
14. Dible JH. Verocay bodies and pseudo-meissnerian corpuscles. J Pathol Bacteriol 1963;85:425-33.
15. Unna PG. Naevi and naevocarcinome. Berl Klin Wochenschr 1893;30:14-6.
16. Masson P. My conception of cellular nevi. Cancer 1951;4:9-38.
17. Levi-Montalcini R. The nerve growth factor 35 years later. Science 1987;237:1154-62.
18. Pincelli C, Fantini F, Giannetti A. Nerve growth factor and the skin. Int J Dermatol 1994;33:308-12.
19. Yaar M, Grossman K, Eller M, et al. Evidence for nerve growth factor-mediated paracrine effects in human epidermis. J Cell Biol 1991;115:821-8.
20. Bröcker EB, Magiera H, Herlyn M. Nerve growth and expression receptors for nerve growth factor in tumors of melanocyte origin. J Invest Dermatol 1991;96:662-5.
21. Real FX, Rettig WJ, Chesa PG, et al. Expression of epidermal growth factor receptor in human cultured cells and tissues: relationship to cell lineage and stage of differentiation. Cancer Res 1986;46:4726-31.
22. Chandler CE, Parsons LM, Hosang M, et al. A monoclonal antibody modulates the interaction of nerve growth factor with PC 12 cells. J Biol Chem 1984;259:6882-9.
23. Cramer SW. The melanocytic differentiation pathway in congenital melanocytic nevi: theoretical considerations. Pediatr Pathol 1988;8:253-65.
24. Argenyi ZB, Ackerman MB. Immunohistochemical characterization of "nevic corpuscles" in melanocytic nevi. J Cutan Pathol 1988;15:293.
25. Van Paesschen M-A, Goovaerts G, Buyssens N. A study of so-called neurotization of nevi. Am J Dermatopathol 1990;12:242-8.
26. Chao MV. The membrane receptor for nerve growth factor. Curr Top Microbiol Immunol 1991;165:39-53.
27. Ernfors P, Wetmore C, Eriksdotter-Nilsson, et al. The nerve growth factor receptor gene is expressed in both neuronal and non-neuronal tissues in the human fetus. Int J Dev Neurosci 1990;9:57-66.
28. Ross AH, Sobue G, Hotta H, et al. Biochemical characterization of the nerve growth factor receptor in neural-related tumors. Curr Top Microbiol Immunol 1991;165:27-37.
29. Hertel C, Schubenel R. Nerve growth factor-induced loss of cell-associated nerve growth factor receptor in human melanoma A875 cells. Neurosci Lett 1992;136:113-7.
30. Ragsdale C, Woodgett J. Trking neurotropic receptors. Nature 1991;350:660-1.
31. Hempstead BL, Martin-Zanca D, Kaplan DR, et al. High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor. Nature 1991;350:678-83.
32. Thompson SJ, Schatteman GC, Gown AM, et al. Monoclonal antibody against nerve growth factor receptor. Am J Clin Pathol 1989;92:415-23.
33. Baker DL, Molenaar WM, Trojanowski JQ, et al. Nerve growth factor receptor expression in peripheral and central neuroectodermal tumors, other pediatric brain tumors, and during development of the adrenal gland. Am J Pathol 1991;139:115-22.
34. Van H, Schlessinger J, Chao MV. Chimeric NGF-EGF receptors define domains responsible for neuronal differentiation. Science 1991:561-3.
35. Yaar M, Woodley DT, Gilchrest BA. Human nevocellular nevus cells are surrounded by basement membrane components: immunohistologic studies of human nevus cells and melanocytes in vivo and in vitro. Lab Invest 1988;58:157-62.
36. Swanson PE, Wick MR. Soft tissue tumors. In: Colvin RB, Bhan AK, McCluskey RT, eds. Diagnostic immunopathology. 2nd ed. New York: Raven, 1995:599-631.